Markets:

Overview

News

Currencies

International

Treasuries

Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY:DNA)

8.800 -0.550 (-5.88%)

Streaming Delayed Price Updated: 12:21 PM EST, Feb 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Moss, Microbes, and the Martian Dream: How Tiny Organisms Are Paving the Way for Off-World Colonies

November 24, 2025

The ambitious dream of humanity establishing permanent settlements beyond Earth is taking a significant leap forward, not through advanced robotics or colossal spacecraft, but with the humble power of...

Via TokenRing AI

Topics Artificial Intelligence Economy

Ginkgo Bioworks Stock Plummets Following Q3 Estimates Miss, Reaffirms FY2025 Outlook Below Consensus ↗

November 07, 2025

Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares are trading lower on Friday. The company released its third-quarter financial results.

Via Benzinga

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

Dell, Select Medical, Century Aluminum And Other Big Stocks Moving Higher On Wednesday ↗

October 08, 2025

Via Benzinga

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

Earnings Scheduled For May 6, 2025 ↗

May 06, 2025

Via Benzinga

Earnings Scheduled For February 25, 2025 ↗

February 25, 2025

Via Benzinga

Earnings Scheduled For November 12, 2024 ↗

November 12, 2024

Via Benzinga

Insights into Ginkgo Bioworks Holdings's Upcoming Earnings ↗

November 11, 2024

Via Benzinga

AI Unlocks Secrets of Intrinsically Disordered Proteins: A Paradigm Shift in Biomedical Design

October 06, 2025

A groundbreaking advancement in artificial intelligence has opened new frontiers in understanding and designing intrinsically disordered proteins (IDPs), a class of biomolecules previously considered...

Via TokenRing AI

Topics Artificial Intelligence Derivatives

5 Healthcare Stocks On Fire This Week ↗

August 21, 2025

Healthcare stocks SNOA, EVOK, KALA, DNA, & SNGX soar with massive momentum gains, signaling breakout potential in biotech & pharma.

Via Benzinga

Ginkgo Bioworks Holdings Inc (NYSE:DNA) Fits the Minervini Trend Template with Strong Technicals and High-Growth Momentum ↗

August 01, 2025

Ginkgo Bioworks (DNA) meets Minervini Trend Template criteria with strong technicals, earnings growth, and momentum, making it a high-growth stock to watch.

Via Chartmill

From Promise to Peril: The Downfall of Ginkgo Bioworks ↗

August 26, 2024

Via Benzinga

Hewlett Packard Enterprise, Magnite, GMS And Other Big Stocks Moving Higher On Monday ↗

June 30, 2025

Via Benzinga

Nvidia-Backed Recursion, Ginkgo Bioworks Rally Following FDA's Decision To End Animal Testing ↗

April 14, 2025

FDA announces plan to end mandatory animal testing of new drugs, replacing it with more effective and human relevant methods.

Via Benzinga

Topics Animal Testing

Fastenal Posts Better-Than-Expected Sales, Joins Simulations Plus, Certara And Other Big Stocks Moving Higher On Friday ↗

April 11, 2025

Via Benzinga

Flywire Posts Downbeat Results, Joins Lemonade, Ginkgo Bioworks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

February 26, 2025

Via Benzinga

US Stocks Likely To Open Higher Ahead Of Nvidia Earnings: S&P 500's Four-Day Fall Was A 'Non-Event,' Says Expert ↗

February 26, 2025

U.S. stock futures rose on Wednesday following two consecutive days of mixed close this week. All futures advanced in premarket trading.

Via Benzinga

Topics Stocks

Why ZoomInfo Technologies Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket ↗

February 26, 2025

Via Benzinga

Why Coherent Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket ↗

February 06, 2025

Via Benzinga

What's Going On With Ginkgo Bioworks Stock This Week? ↗

September 18, 2024

Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares continue to trade higher after rising nearly 10% on Tuesday. Here's a look at what's going on.

Via Benzinga

Why Ginkgo Bioworks Holdings Stock Raced 9% Higher Today ↗

September 17, 2024

The company is forging ahead with next-generation drug development solutions.

Via The Motley Fool

Google Cloud Expands Its Partnership With Ginkgo Bioworks For Two New AI-Tools Faster Drug Development ↗

September 17, 2024

Ginkgo Bioworks introduces a protein large language model and API, developed with Google Cloud, to streamline drug discovery by leveraging AI and proprietary biological data, offering affordable and...

Via Benzinga

Topics Artificial Intelligence

Ginkgo Bioworks Stock Is Rallying Tuesday: Here's Why ↗

September 17, 2024

Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares are surging Tuesday after the company announced the launch of its new protein large language model (LLM) built on Google Cloud.

Via Benzinga

Compass Minerals, Torrid Holdings, Icahn Enterprises, Hewlett Packard Enterprise And Other Big Stocks Moving Higher On Tuesday ↗

September 17, 2024

Via Benzinga

Down a Monstrous 90% This Year, Is There Any Hope Left for Ginkgo Bioworks Investors? ↗

September 05, 2024

Could this beaten-down stock turn things around in the near future?

Via The Motley Fool

2 Big Risks and 2 Big Opportunities for Ginkgo Bioworks Stock ↗

September 03, 2024

The risks may resolve in a year or so but seizing the opportunities will take longer.

Via The Motley Fool

This 1 AI Stock Could Revolutionize Biotech and Pharma ↗

September 02, 2024

The company is using artificial intelligence, and planning to help others use AI empowered by its data collection.

Via The Motley Fool

Topics Artificial Intelligence

Down 88% in 1 Year, What's Next for Ginkgo Bioworks Stock? ↗

August 24, 2024

Its ambitious business model may not be sustainable.

Via The Motley Fool

Down 86% This Year, Is Ginkgo Bioworks Stock a Bargain Now? ↗

August 15, 2024

Have shares of the troubled life sciences business fallen too far?

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY:DNA)

Headline News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

Starting at $3.75/week.

Subscribe Today